Tag archive for ‘Millendo Therapeutics’
MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Thursday, September 24th, 2020

Millendo Therapeutics begins human trial of VMS drug candidate MLE-301

Millendo Therapeutics has started a phase 1 clinical trial of its selective neurokinin 3 receptor (NK3R) antagonist MLE-301, which is being developed for the treatment of menopausal women with vasomotor symptoms More...

By pharmanewsdaily On Sunday, December 9th, 2018

Millendo Therapeutics wraps up merger with OvaScience

Millendo Therapeutics, a clinical-stage biopharma company engaged in developing drugs for orphan endocrine diseases, has wrapped up a previously announced merger with OvaScience, a Massachusetts-based biotech company More...